Apr 9, 2024, 15:56
We’ve been energized and inspired by our time at AACR2024 – Agenus
Agenus shared a post on LinkedIn:
“We’ve been energized and inspired by our time at AACR2024.
Yesterday our Vice President of Research, Dhan Chand, presented preclinical data on the activity of BMS-986442, Bristol Myers Squibb’s bispecific TIGIT program that was licensed from Agenus in 2021 (formerly AGEN1777). View the presentation.”
Source: Agenus/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14